Rotraxate
Rotraxate (TEI 5103) is an orally active anti-ulcer compound. Rotraxate can increase blood flow to the gastric mucosa and promote the integrity of the gastric mucosa. Rotraxate can be used to study the protective effects of drugs on the gastric mucosa, especially in investigating how drugs can prevent or treat gastric ulcers by acting directly on the gastric mucosa.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 92071-51-7
- Formule: C17H23NO3
- Masse moléculaire:289.37
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Chemical Information
-
CAS No. 92071-51-7
-
Masse moléculaire 289.37
-
Formule C17H23NO3
-
SMILES
O=C([C@H]1CC[C@@H](CC1)CN)C2=CC=C(C=C2)CCC(O)=O
-
Synonyms
TEI 5103; TG 51
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)